Plenty of weight-loss drugs have failed, too Anti-obesity drugs with other targets such as those sold under the brand names Qsymia, Contrave, Reductil and Accomplia resulted in weight loss (typically less than 10%) but were accompanied by side effects such as increased heart rate, heart disease and psychological safety concerns such as anxiety and suicidal thoughts
Future studies of medical efficacy should focus on improving RCT design, implementation and results reporting to improve the quality of evidence generated by each study
Medical Factors Medical factors could be impacting your weight loss journey
This represents a slight increase compared to 2023, highlighting a stagnation of progress in malaria control
For B2B buyers, product developers, and formulators, the practical implications are significant